Pfizer and BioNTech announced Friday that they are postponing their application to the Food and Drug Administration for the companies’ COVID-19 vaccine for children under the age of 5.

What they’re saying: The companies said they “will wait for the three-dose data” because they “believe it may provide a higher level of protection in this age group.”